| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |